# Bromocriptine mesylate

NDC: 0781-5325
Generic name: Bromocriptine mesylate
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 19980113

FDA application: ANDA074631

## Active ingredients

- BROMOCRIPTINE MESYLATE: 2.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0781-5325"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0781-5325
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c43c300d-8aec-4020-984a-42c1a917c08f